Literature DB >> 3218608

Ventricular arrhythmias parallel cardiac histamine efflux after coronary artery occlusion in the dog.

A A Wolff1, R Levi.   

Abstract

Release of cardiac histamine by immunologic and pharmacologic stimuli is known to provoke ventricular arrhythmias. Augmented histamine efflux from ischemic myocardium has been proposed but remains controversial. The purpose of this study was to determine whether cardiac histamine efflux is precipitated by coronary artery occlusion and if so, whether histamine efflux is associated with the development of early ischemic ventricular arrhythmias. The left anterior descending coronary artery was occluded while recording a continuous electrocardiogram and coronary sinus blood was sampled frequently during the first 30 min of coronary artery occlusion in pentobarbital-anesthetized, open-chest dogs. Coronary sinus histamine concentration rose from a mean baseline of 0.06 +/- 0.10 ng/ml (+/- SD) before coronary artery occlusion to a mean peak of 0.61 +/- 0.40 ng/ml after coronary artery occlusion (p less than 0.0001; n = 14). The median peak coronary sinus histamine concentration was significantly greater in dogs that suffered ventricular fibrillation after coronary artery occlusion (n = 4) than in those that did not (n = 10) (0.86 ng/ml vs. 0.37 ng/ml; p = 0.05). The area under the coronary sinus histamine concentration-vs.-time curve ("total cardiac histamine efflux") correlated directly with the total number of ventricular premature contractions during the first 30 min after coronary artery occlusion (r = 0.81; p less than 0.005; n = 10), and with infarct size (r = 0.91; p less than 0.01; n = 6). Thus, during acute myocardial ischemia, the coronary sinus histamine concentration increases simultaneously with the development of early ischemic ventricular arrhythmias and in proportion to their severity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3218608     DOI: 10.1007/bf01965035

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  36 in total

Review 1.  Biochemical aspects of arrhythmogenesis and ventricular fibrillation.

Authors:  L H Opie; D Nathan; W F Lubbe
Journal:  Am J Cardiol       Date:  1979-01       Impact factor: 2.778

2.  Histamine and lactate dehydrogenase (LDH) release in ischemic myocardium of the guinea-pig.

Authors:  E Masini; E Giannella; S Bianchi; P F Mannaioni
Journal:  Agents Actions       Date:  1987-04

3.  A metabolic cause for arrhythmias during acute myocardial hypoxia.

Authors:  V A Kurien; M F Oliver
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

4.  Histamine receptors in the human heart.

Authors:  R Ginsburg; M R Bristow; E B Stinson; D C Harrison
Journal:  Life Sci       Date:  1980-06-30       Impact factor: 5.037

5.  Cardiovascular effects of ranitidine and cimetidine during acute myocardial ischaemia in anaesthetized dogs.

Authors:  S Dai
Journal:  Agents Actions       Date:  1986-10

6.  Reduction of ventricular fibrillation threshold by histamine: resolution into separate H1- and H2-mediated components.

Authors:  J P Trzeciakowski; R Levi
Journal:  J Pharmacol Exp Ther       Date:  1982-12       Impact factor: 4.030

7.  Ventricular arrhythmias in cardiac anaphylaxis.

Authors:  J Senges; U Randolf; H Katus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

8.  Histamine modification of spontaneous rate and rhythm in infarcted canine ventricle.

Authors:  M S Gaide; C B Altman; J S Cameron; C J Kaiser; R J Myerburg; A L Bassett
Journal:  Agents Actions       Date:  1984-12

9.  Enhanced adverse electrophysiologic effects of histamine after myocardial infarction in guinea pigs.

Authors:  J S Cameron; M S Gaide; P L Goad; C B Altman; J Cuevas; R J Myerburg; A L Bassett
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

10.  The cardiac pharmacology of tiotidine (LCL 125, 211): a new histamine H2-receptor antagonist.

Authors:  J P Trzeciakowski; R Levi
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

View more
  5 in total

1.  Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity.

Authors:  Maria A Mitry; Dimitri Laurent; Britny L Keith; Elizabeth Sira; Carol A Eisenberg; Leonard M Eisenberg; Sachindra Joshi; Sachin Gupte; John G Edwards
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

Review 2.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

3.  Mast cell degranulation--a mechanism for the anti-arrhythmic effect of endothelin-1?

Authors:  S K Walsh; K A Kane; C L Wainwright
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

4.  Histamine deficiency exacerbates myocardial injury in acute myocardial infarction through impaired macrophage infiltration and increased cardiomyocyte apoptosis.

Authors:  Long Deng; Tao Hong; Jinyi Lin; Suling Ding; Zheyong Huang; Jinmiao Chen; Jianguo Jia; Yunzeng Zou; Timothy C Wang; Xiangdong Yang; Junbo Ge
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

5.  Glucagon effects on 3H-histamine uptake by the isolated guinea-pig heart during anaphylaxis.

Authors:  Mirko Rosic; Oberdan Parodi; Vladimir Jakovljevic; Maja Colic; Vladimir Zivkovic; Vuk Jokovic; Suzana Pantovic
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.